Aim: Gambogic acid (GA) is the major active compound of Gamboge, a brownish or orange resin exuded from Garcinia hanburryi tree in Southeast Asia. Previous studies have demonstrated that GA exhibits potent anticancer effects by inducing cell cycle arrest or apoptosis in many types of cancer cell lines and blocking angiogenesis via inhibition of vascular endothelial cell proliferation and migration. Proliferation and migration of vascular smooth muscle cells (VSMCs) are critical steps in the progress of atherosclerosis and restenosis after angioplasty. In the present study, we investigated whether GA has an inhibitory effect on the proliferation and migration of VSMCs and its possible mechanism. Methods: The inhibitory effect of GA on the proliferation induced by PDGF-BB and EGF was measured by using Cell number counting assay and [ 
Introduction
Abnormal proliferation and migration of vascular smooth muscle cells (VSMCs) is a major contributor to atherosclerosis and restenosis after angioplasty. PLC 1, phospho-PLC 1 (Ser1248), ERK1/2, phospho-ERK1/2 (Thr202/Tyr204), AKT, phospho-AKT (Ser473), SAPK/JNK, EGFR, Phospho-EGFR (Tyr1068) phospho-SAPK/JNK (Thr183/Tyr185), phospho-tyrosine and Rac1/2/3 antibodies were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA), PDGF-BB, EGF, cyclin D1, cyclinE, CDK2, and CDK4 antibodies were supplied by Santa Cruz Biotechnology Corporation (Santa Cruz, CA, USA), while the Rac1 activation kit was bought from Assay Designs Inc. (Michigan, USA). The other chemicals were of the highest analytical grade commercially available.
Cell Culture
VSMCs were isolated from Sprague-Dawley rats using the method described previously 16) . Cells were cultured in Dulbecco's modified Eagle's medium (Gibco, Carlsbad, CA, USA) supplemented with 10% heat-inactivated FBS, 100 U/mL penicillin and 100 g/mL streptomycin at 37 in a humidified 5% CO2 incubator. VSMC purity was further confirmed by immunocytochemistry staining with alpha-smooth muscle actin monoclonal antibody. VSMCs between passages 4 and 8 were used in experiments and made quiescent by serum starvation in DMEM containing 0.1% FBS for 24 hrs 17) .
Measurement of Cell Proliferation and DNA Synthesis Cell Proliferation
Rat aortic VSMCs (2 10 4 ) were seeded into 24-well culture plates and cultured in DMEM medium containing 10% FBS and grown to 70% confluence. VSMCs were then incubated with serum-free medium for 24 hrs and then treated with GA at final concentrations of 0.25 to 2.0 mol/L for another 24 hrs. The cells were stimulated with or without PDGF-BB (50 g/L) or EGF (10 g/L) for 24 hrs and counted by hemocytometer.
DNA Synthesis
VSMCs that had been grown to 70% confluence were serum-starved for 24 hrs, and then treated with GA for another 24 hrs before PDGF-BB or EGF stimulation. After cells were stimulated by PDGF-BB (50 g/L) or EGF (10 g/L) for 8 hrs and [ 3 H]-thymidine (1 Ci/mL) was added and incorporated with VSMCs for another 16 hrs, the medium was aspirated to terminate the reaction. The cultures were washed sequentially with PBS containing 10% trichloroacetic acid and ethanol/ether (1:1, v/v) on ice. Acid-insoluble [
3 H]-thymidine was extracted by 1.0 mol/L NaOH with 500 L per well; the extracted solution was then Platelet-derived growth factor (PDGF) is known to be an important stimulator [1] [2] [3] . Much evidence indicates that PDGF-BB and PDGF receptor (PDGFR-)-mediated signals are particularly important for vascular remodeling and neointima formation after vascular injury [4] [5] [6] . Therefore, it will become a novel strategy for pharmacologic inhibition of PDGF-induced VSMC proliferation and migration during lesion development.
PDGFR-activation is associated with a number of Src homology region 2-containing signaling enzymes, including RasGAP, the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K) and phospholipase C (PLC) 1 7) . These signaling molecules selectively associate with phosphorylated tyrosine residues within the cytoplasmic domain of the PDGFR, and their activation induces a highly specific signal transduce cascade. ERK, Akt, JNK and small G proteins, including rho and rac-1, are involved in downstream mediators of PDGFR-, and they all ultimately take part in PDGF-dependent cellular responses, such as cell cycle progression, migration, and survival 8, 9) . It was reported in Chinese traditional medicine documents that Gamboge resin has potent biological effects, such as hemostasis, anti-inflammation, antioxidation and anti-infection. Gambogic acid (GA, C38H44O8) is the major active compound of Gamboge, a brownish or orange resin exuded from the Garcinia hanburryi tree in Southeast Asia. Previous studies have demonstrated that GA has potent anticancer, anti-inflammatory activity and inhibits angiogenesis both in vivo and in vitro by suppressing the phosphorylation of AKT, ERK, c-Src, FAK and VEGFR2 [10] [11] [12] [13] [14] [15] . However, the effects of GA on the proliferation and migration of VSMCs are not clearly understood. In this study, we investigated the effects of GA on rat VSMC proliferation and migration stimulated by PDGF-BB and the underlying molecular mechanism. We found that GA significantly inhibited the proliferation and migration of VSMCs by suppressing the phosphorylation of PDGFR-and its downstream kinases and small G protein rac1 activity. GA may be developed to a potential drug in the prevention and treatment of atherosclerosis.
Materials and Methods

Materials and Reagents
GA (20 mg) was kindly provided by Professor Guo Qinglong at China Pharmaceutical University. PDGF-BB and EGF were purchased from R & D Corporation (Minneapolis, USA). [ mixed with 3 mL scintillation cocktail (Ultimagold; Packard Bioscience, CT, USA) and radioactivity was quantified as count per minute (CPM) using a liquid scintillation counter (LS3801; Beckman, Düsseldorf, Germany).
Cell Cycle Analysis
To estimate the proportion of VSMCs in different phases of the cell cycle treated by GA, cellular DNA contents were measured by flow cytometry. VSMCs were starved for 24 hrs and then treated with GA for another 24 hrs. The cells were collected by trypsinization after stimulation with PDGF-BB (50 g/L) or EGF (10 g/L) for 24 hrs. They were fixed by 70% ethanol overnight at 4 . The fixed VSMCs were briefly vortexed and centrifuged at 15,000×g for 5 minutes. The ethanol was discarded and the pellets were stained with 0.5 mL propidium iodide (PI) solution (50 g/mL PI in buffer containing 100 g/mL RNase A), and incubated for 1 hr at room temperature. The complexes of PI-DNA were measured using a FACSCalibur (Beckman Coulter Co., USA). The rates of G0/G1, S and G2/M phases were analyzed.
Annexin-V and PI Double-Staining (Apoptosis) Assay
Apoptotic or necrotic cells were detected by double staining with FITC-conjugated annexin V and PI, using the Annexin V-FITC Apoptosis Detection kit (Bipec Biopharma, USA) according to the manufacturer's instructions. VSMCs were incubated with serum-free DMEM medium for 24 hrs, and then treated with GA at an increasing concentrations (0.25 − 2.0 mol/L) for another 24 hrs before being stimulated by PDGF-BB or EGF. After VSMCs were treated by PDGF-BB or EGF for 24 hrs, the cells were harvested and rinsed twice with cold PBS. Flow cytometric analysis (Beckman Coulter Co., USA) was performed immediately after staining. Finally, the percentage of viable cells (annexin V and PI negative), apoptotic cells (annexin V negative and PI positive) and necrotic cells (annexin V and PI positive) were analyzed.
Cell Migration Assay
Cell migration was measured with 24-well Transwell inserts (Corning and Transwell, NY, USA) as previously described 18) . In brief, a polycarbonate membrane (pore size, 8.0 m) was incubated with 10 mg/mL gelatin (Sigma, USA) overnight before use. The lower chamber was filled with 500 L DMEM medium with PDGF-BB (10 g/L) 19) or without PDGF-BB as a control. The upper chamber was filled with the cell suspension (200 L, 5 10 5 /mL) containing GA at increasing concentration. Cells were incubated in the assembled chamber for 24 hrs. Cells which migrated to the lower face of the membrane were fixed with methanol and stained with 0.1% crystal violet in 20% methanol. The inserts were rinsed in PBS 3 times and air-dried overnight. Crystal violet was lysed with 500 L 50% ethanol containing 0.1 mol/L sodium citrate. The absorption value was measured at 585 nm using a spectrophotometer, Multiskan MK3 (Thermo, Finland) 15) .
Western Blotting Analysis
Rat VSMCs seeded in 6-well plates were incubated in serum-free DMEM medium with GA for 24 hrs. VSMCs were then stimulated by 50 g/L PDGF-BB or EGF (10 g/L) and lysed in SDS lysis buffer containing a protease inhibitor, PMSF and a phosphotase inhibitor. Lysates were centrifuged at 13000g for 15 minutes, and then the supernatants were collected. Protein concentration was measured using a BCA protein assay reagent (Beyotime Institute of Biotechnology, Shanghai, China). 10% SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) was performed for protein separation. Proteins were transferred to a PVDF membrane (Millipore Corp., USA). The membranes were blocked by 5% non-fat milk in Tris-buffered saline containing 0.1% Tween 20 (TBS/T) at 4 overnight and then incubated with 1:1000 dilution of each of the following antibodies: anti-EGFR, anti-phospho-EGFR, anti-phopho-tyrosine, anti-PDGFR-, anti-phospho-PDGFR-, anti-ERK1/2, anti-phospho-ERK1/2, anti-PLC-1, anti-phospho-PLC-1, anti-AKT, anti-phospho-AKT, anti-JNK, anti-phospho-JNK, anti-cyclin D1, anticyclin E, anti-CDK2, anti-CDK4 and anti-Rac1/2/3. After membranes were incubated in the primary antibody at 4 overnight and then washed with TBST 3 times, 1:5000 dilution of horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit immunoglobulin (Bioworld, USA) was applied for 1 hr at room temperature. Specific protein bands were visualized by enhanced chemiluminescence (ECL) detection reagent (Applygen Technologies Inc., Beijing, China). The levels of phospho-PDGFR-, phospho-PLC-1, phospho-ERK1/2, phospho-AKT, and phospho-JNK were normalized to total PDGF-R , PLC-1, total ERK1/2, total AKT, total JNK values, respectively. Band intensities were quantified by the Quantity One program 20) .
Dot Binding Assay
A nitrocellulose (NC) membrane was soaked in transbuffer (25 mM Tris, 199.8 mM glycine and 20% methanol) for 30 s. Recombinant PDGF-BB, EGF, BSA (all 10 ng/ L) and GA (1 g/ L) were directly spotted on the same membrane due to the small volume of samples. The membrane was then blocked with BSA (5% in PBS) for 30 minutes. After being washed with PBS 3 times, the membrane was incubated with PDGF-BB or EGF (0.5 g/mL) in PBS for 1 hr at room temperature and then washed with PBS 3 times. The membrane was incubated with anti-PDGF-BB antibody or EGF antibody (2 g/ L in 1% BSA-containing PBS) for 1 hr at room temperature. 1:5000 dilution of horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit immunoglobulin (Bioworld, USA) was applied for 1hr at room temperature. Specific protein dots were visualized by enhanced chemiluminescence (ECL) detect reagent (Applygen Technologies Inc., Beijing, China) 21) .
Measurement of Rac-1 Activation
Rac-1 activation was measured using GST-fusion protein containing the P21-binding domain (PBD) of P21-activated kinase 1 (Pak 1) to affinity precipitate active Rac1 (GTP-Rac1) from cell lysates. VSMCs at 70 − 80% confluence were incubated in serum-free DMEM medium for 24 hrs, followed by GA treatment at the indicated concentrations for an additional 24 hrs. After stimulation of PDGF-BB for 5 minutes 22) , culture medium was carefully removed and the cells were rinsed once with ice-cold TBS. Six hundred microliters of lysis/binding/wash buffer was added to the plates. Cells were scraped and transferred to a microcentrifuge tube which was vortexed and incubated on ice for 5 minutes. Cell lysates were centrifuged at 16000g at 4 for 15 minutes. One hundred microliters of supernatants were used to compare protein amounts. The remaining 500 L supernatant was incubated with GST-PAK-CD fusion protein, which bound to glutathione-coupled Sepharose beads at 4 for 30 minutes. The beads and proteins bound to the fusion protein were washed three times in excess lysis buffer, eluted in sample buffer, and then analyzed for bound rac-1 by Western blotting.
Statistical Analysis
The experimental results are expressed as the mean S.D. Student's t -test and ANOVA with multiple comparisons using the Newman-Keuls test were used for statistical analysis. Statistical significance was accepted at p 0.05.
Results
Effects of GA on PDGF-BB-Mediated Aortic Smooth Muscle Cell Proliferation and DNA Synthesis
GA inhibited PDGF-BB-induced proliferation of rat VSMCs in a concentration-dependent manner (Fig. 1A) . The number of VSMCs was significantly increased after 50 g/L PDGF-BB treatment (70. (Fig. 1B) .
The effect of GA on DNA synthesis was assayed using [ mol/L GA were 27.2%, 41.3%, 46.8%, and 58.7%, respectively, with PDGF-BB treatment. GA also inhibited DNA synthesis induced by EGF in rat VSMCs in a concentration-dependent manner (Fig. 1D) .
Effects of GA on Cell Cycle Analysis
Effects of GA on cell cycle progression were also analyzed by flow cytometry analysis (Fig. 2A) . The serum deprivation of VSMCs in primary culture for 24 hrs resulted in approximately 94.7 1.6% synchronization of the cell cycle in the G0/G1 phase. The percentage of cells in the S phase increased from 3.5 1.2 to 12.8 2.7% for 24 hrs after PDGF-BB was added. In contrast, cell cycle progression was blocked significantly in GA pre-treated cells. The reduced percentage of cells in the S phase was 10.2 1.8% (p 0.05, n 3, duplicate), 8.4 1.7%, 5.6 1.2% and 3.9
1.0% (p 0.01, n 3, duplicate) at concentrations of 0.25, 0.5, 1.0 and 2.0 mol/L, respectively. These findings indicated that GA might act in the early events of the cell cycle to be effective against DNA synthesis induced by PDGF-BB. GA also blocked cell progression induced by EGF (Fig. 2B) .
Effect of GA on Viability of Rat Aortic VSMCs
As shown in Fig. 3 , apoptotic cells were doublestained with annexin V and propidium iodide 24 hrs after stimulation with PDGF-BB or EGF in the presence or absence of various concentrations of GA (0.25, 0.5, 1.0 and 2.0 mol/L). The proportions of apoptotic cells and necrotic cells were not significantly different in PDGF-BB and EGF-stimulated rat VSMCs pretreated with various concentrations of GA, suggesting that the antiproliferative effect of GA was not due to the induction of apoptosis and necrosis in rat VSMCs.
Effects of GA on PDGF-BB Induced Cell Migration
As shown in Fig. 4A , PDGF-BB stimulation significantly induced the migration of rat VSMCs by 1.7-fold (data shown as absorption value of crystal violet). GA pretreatment in the upper chamber significantly reduced the increasing cell migration stimulated by PDGF-BB. Compared with the DMSO control group without GA after PDGF-BB stimulation, the number of cells that passed through the membrane was reduced by 17.2%, 32.2%, 35.5% and 45.8% after pretreatment with GA at concentrations of 0.25, 0.5, 1.0 and 2.0 mol/L respectively. Fig. 4B showed that VSMCs stained with crystal violet migrated through the polycarbonate membrane, indicating that GA inhibited cell migration stimulated by PDGF-BB in a concentration-dependent manner.
Effects of GA on PDGF-BB-Induced PDGFR and Tyrosine Phosphorylation
Rat VSMCs were incubated with serum-free DMEM medium for 24 hrs, and then treated with GA for an additional 24 hrs. Protein was harvested at 1 minute and 5 minutes after stimulation by PDGF-BB (50 g/L) 3, 23, 24) . As shown in Fig. 5 , pretreatment with GA at 0.25, 0.5, 1.0, and 2.0 mol/L significantly inhibited PDGFR and tyrosine phosphorylation stimulated by PDGF-BB compared with the control group without GA in a concentrationdependent manner. In the EGF stimulation group, GA also inhibited EGFR phosphorylation and tyrosine phosphorylation in a concentration-dependent manner.
Effects of GA on PLC-1, ERK1/2, PI3K/Akt and JNK Phosphorylation
The downstream intracelluar signaling of PDGFR-has been relatively well characterized [25] [26] [27] . These signaling molecules, including ERK1/2, PLC-1, AKT, and JNK are involved in the PDGFR pathway.
After quiescent VSMCs had been treated with GA for an additional 24 hrs, the cell lysis was harvested at 5 minutes (ERK1/2, PLC-1) 28 ) and 15 minutes (AKT, JNK) 22, 29) after stimulation with PDGF-BB (50 g/L). Western blotting results are shown in Fig. 6 and 7 , and the increased phosphorylation of ERK1/2, PLC-1, Akt and JNK stimulated with PDGF-BB was significantly inhibited by pretreatment with GA in a concentration-dependent manner. 
A B
Effects of GA on Cyclin D1, Cyclin E, CDK4 and CDK2 Expression
As shown in Fig. 8 , there was an increase in the expression of Cyclin D1, Cyclin E, CDK4 and CDK2 after stimulation with 50 g/L PDGF-BB for 24 hrs. While being pretreated with GA (0.25 − 2.0 mol/L) for 24 hrs, the expressions of Cyclin D1, Cyclin E, CDK4 and CDK2 were significantly inhibited in a concentration-dependent manner.
GA Binds PDGF-BB Assay
As shown in Fig. 9 , recombinant rat PDGF-BB, EGF and GA were immobilized on the membrane. After incubation with or without PDGF-BB or EGF, the membrane was incubated with antibody directed against PDGF-BB or EGF and then developed. It was shown that immobilized PDGF-BB and EGF could be recognized by the anti-PDGF-BB antibody and anti-EGF antibody. A negative binding signal was detected on the GA and BSA spot incubated with PDGF-BB and EGF.
Effects of GA on Rac1 Activation
Rac-1 activity was measured with GST pull-down assays. As shown in Fig. 10 , there was transient activation of Rac-1 after stimulation with 50 g/L PDGF-BB for 5 minutes 22) , while pretreatment with GA (0.25 mol/L − 2.0 mol/L) resulted in the concentrationdependent inhibition of Rac-1 activity.
Discussion
It has been well established that abnormal proliferation of VSMCs and migration of VSMCs from the media to the intima play a central role in the development of atherosclerosis and restenosis after angioplasty 30) . PDGF is known to be an important cytokine which stimulates cell growth and migration. Much A B evidence indicates that PDGF-BB and its receptor PDGFR--mediated signals are particularly important for vascular remodeling and neointima formation after vascular injury. Moreover, inhibition of PDGF signaling, which potentially prevents atherogenesis, has been confirmed in various models 5, 31, 32) . Therefore, inhibition of PDGF-induced VSMC proliferation and migration represents a key pharmacologic strategy during atherogenesis development.
In the present study, our data confirmed that the proliferation and DNA synthesis of rat VSMCs induced by PDGF-BB were suppressed by pretreatment with GA in a concentration-dependent manner. Previous studies have shown that GA can induce apoptosis in some tumor cells 13, 33, 34) . Our results suggested that the antiproliferative effect of GA was not due to apoptosis or necrosis (Fig. 3) . Our further investigation indicated that the antiproliferative effects of GA were associated with the increased accumulation of cells in the G0/G1 phase of the cell cycle (Fig. 2) ; however, our findings also showed that GA inhibited proliferation, DNA synthesis and cell progression induced by EGF in a concentration-dependent manner, implying that the inhibition effects of GA were not specific to PDGF-BB stimulation.
Cell cycle regulatory molecules, such as CDKs and cyclins, are related to the G1 phase of the cell cycle [35] [36] [37] . In the present study we found that VSMC cell cycle arrest in G0/G1 phase was induced by GA pretreatment; therefore, the effects of GA on expressions of CDK2, CDK4, cyclin E and D1 were further examined. Our data showed that increasing expressions of CDK2, cyclin E, CDK4 and cyclin D1 were inhibited by pretreatment with GA in a concentration-dependent manner, indicating that the effects of GA on cell cycle arrest might be due to the downregulation of CDK/cyclin complex expression. Migration is another important factor in vascular remodeling and neointima formation after vascular injury. Our data showed that GA markedly suppressed rat VSMC migration induced by PDGF-BB in a concentration-dependent manner.
Rac-1 (21 kDa) is a member of the Rho family of small GTPases. Rho proteins are very important regulators of the actin cytoskeleton, serve as transducers between mechanical forces, cell morphology, and gene regulation, and thus regulate cellular motility. Ryu and coworkers demonstrated that the suppression of rac-1 activation resulted in the significant negative regulation of cell migration 38) . It has been well established that rac1 is dependent on the activation of PDGF-R and is marked at low PDGF concentrations 19, 39) . Our findings showed an increase in Rac-1 PDGF-BB (100 ng) and GA (GA, 10 g) were applied to the NC membrane. The membrane was incubated with PDGF-BB, followed by incubation with anti-PDGF-BB antibody, and developed. (B) Rat EGF (100 ng) and GA (GA, 10 g) were applied to the NC membrane. The membrane was incubated with EGF, followed by incubation with anti-EGF antibody, and developed. activity after PDGF-BB (10 g/L) stimulation for 5 minutes, while pretreatment with GA (0.25 − 2.0 mol/L) resulted in concentration-dependent inhibition, which indicated that the inhibition effect of GA on rat VSMCs migration was related to Rac-1 activity inhibition.
Rac-1 activity is crucial for PDGF-dependent migration of VSMCs and the tyrosine phosphorylation of PDGF-R is part of the early signaling cascade of rat aortic VSMC proliferation 7, 37, 40) . GA actually inhibited Rac-1 activity and tyrosine phosphorylation of PDGF-R stimulated by PDGF-BB in the same concentration range that inhibited rat aortic VSMC proliferation, DNA synthesis, cell cycle progress and migration (Fig. 5) . It was suggested that PDGF-R was the upstream block point for GA. Interestingly, our findings also showed that GA inhibited EGFR phosphorylation in a concentration-dependent manner. Because the activation of PDGFR and EGFR depends on tyrosine phosphorylation, the level of tyrosine phosphrylation was also examined. The data showed that tyrosine phosphorylation stimulated by PDGF-BB and EGF was inhibited significantly in the same manner as PDGFR and EGFR phosphorylation, which indicated that GA inhibition effects were due to the inhibition of tyrosine phosphorylation. Dotbinding assay also showed that GA did not bind with PDGF-BB or EGF.
To understand that inhibition of PDGF-BBinduced phosphorylation of PDGF-R by GA also resulted in the inhibition of the downstream intracellular signaling transduction pathway, the levels of p-ERK, p-PLC, p-AKT and p-JNK in GA-treated VSMCs were also examined. As shown in Fig. 6, 7 and 8, pretreatment of VSMCs with GA for 24 hrs resulted in a marked decrease of p-ERK and p-PLC (5 minutes after stimulation with PDGF-BB), and p-AKT and pi-JNK (15 minutes after stimulation with PDGF-BB) in a concentration-dependent manner.
Taken together, these observations show that inhibition effects on the proliferation and migration of GA are mediated by PLC-1, MEK-ERK1/2, PI3/ AKT, SAPK/JNK and Rac-1 activation through the inhibition of PDGF-R tyrosine kinase in VSMCs. Furthermore, GA arrests cell cycle progression in the G0/G1 phase by downregulating the expression of cyclin D1, cyclin E, CDK4 and CDK2 proteins. Our study suggests that GA could be used as a preventive agent for the progression of vascular complications, such as restenosis after angioplasty and atherosclerosis.
